Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / A New Clue in Developmental Disorders
Neurology Biochemistry and molecular biology Genetics and epigenetics Insights

A New Clue in Developmental Disorders

Bi-allelic mutations associated with intellectual disability and brain abnormalities

02/20/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Report: A New Clue in Developmental Disorders

Overview

Expand on the role of ASTN1 in neuronal migration and its implications for brain structure.

Background

Neurodevelopmental disorders (NDDs) significantly impact children and adolescents, affecting approximately 15% of this population worldwide. Understanding the genetic underpinnings of these disorders is crucial for accurate diagnosis and effective management. The identification of ASTN1 as a gene associated with NDDs may enhance genetic counseling and family risk assessment.

Data Highlights

The study identified 18 individuals from 12 unrelated families with likely damaging bi-allelic variants in the ASTN1 gene. Most individuals exhibited developmental delays or intellectual disabilities, with additional features such as autism spectrum disorder and epilepsy.

Key Findings

Incorporate details about the genetic patterns, including heterozygous variants.

Clinical Implications

Highlight the potential for improved patient outcomes through early genetic testing.

Conclusion

The recognition of ASTN1-related neurodevelopmental disorders emphasizes the importance of genetic testing in pediatric practice. Improved understanding of these conditions can enhance patient care and family support.

References

  1. The Pathologist, The Pathologist, 2026 -- A New Clue in Developmental Disorders
  2. BMC Psychiatry (Springer) — Thorough clinical child psychiatric diagnostic evaluation and validation of the Autism- Tics, ADHD and other comorbidities inventory (A-TAC) in a population-based sample of 9-year-olds
  3. BMC Psychiatry (Springer) — Characterizing Symptoms of SpLD, ADHD, and ASD in Chinese Children: A Biopsychosocial and Transdiagnostic Approach
  4. Genetic Evaluation of the Child With Intellectual Disability or Global Developmental Delay: Clinical Report
  5. the analytical scientist — Uncovering Autism’s Earliest Metallic Traces with LIBS
  6. BMC Psychiatry (Springer) — ADHD comorbidity in preschoolers with developmental language disorder: comparative neurodevelopmental profiles and associated risk factors
  7. The Pathologist | A New Clue in Developmental Disorders
  8. Genetic Evaluation of the Child With Intellectual Disability or Global Developmental Delay: Clinical Report
  9. Full article: Diagnostic and clinical utility of exome sequencing and chromosomal microarray in children with GDD/iD: a meta-analysis

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Biochemistry and molecular biology
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Biochemistry and molecular biology
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

qPCR Infectious Disease Detective
Biochemistry and molecular biology
qPCR: Infectious Disease Detective

January 4, 2024

3 min read

How quantitative polymerase chain reaction really hits the mark in epidemic control and ID detection

Case of the Month
Biochemistry and molecular biology
Case of the Month

January 11, 2022

1 min read

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.